NATHALIE HARROY

About NATHALIE HARROY

Nathalie Harroy is an experienced French life-sciences executive whose career has been built around human resources, organizational development, and talent support in research-driven pharmaceutical companies. She has served as Head of Human Resources at Inventiva since the company’s inception in 2012, making her one of the firm’s long-standing leadership figures and a key holder of institutional knowledge. Inventiva confirmed in 2026 that she remained with the company and continued to contribute to its next phase of growth. Before joining Inventiva, Harroy spent roughly three decades developing HR expertise in the pharmaceutical sector, with a strong focus on R&D environments. She started her career at Urgo Laboratories and then joined Fournier Laboratories in 1994. There, she devoted her work to research and development and later, in 2001, helped shape a new Scientific Affairs organization by supporting the company’s evolving staffing and capability needs. After Fournier was acquired by Solvay and later Abbott, she also contributed to cross-functional HR projects in France for Solvay Pharmaceuticals and Abbott Pharmaceuticals. At Inventiva, Harroy played an important role in building the human infrastructure of a clinical-stage biotech company that has grown into a publicly listed business on Euronext Paris and Nasdaq. Her responsibilities have included supporting recruitment, organizational scaling, and the preservation of a performance-oriented culture in a highly specialized R&D setting. Her long tenure has given her a deep understanding of the company’s history, structure, and operating model, which is especially valuable in a sector where continuity and execution discipline matter. Her professional profile reflects a combination of operational HR leadership, scientific-industry fluency, and experience in regulated environments. Across her career, she has worked at the intersection of people strategy and business transformation, supporting companies through acquisitions, organizational change, and sustained innovation. In a biotech context, that background positions her as a seasoned executive able to align workforce strategy with long-term development priorities, particularly in R&D-intensive organizations.